Skip to content
Sign up free
News

Study Casts Doubt on DEA Marijuana Classification

Study Casts Doubt on DEA Marijuana Classification

By Thomas G Brown

2-minute read

For decades the US government and the DEA have classified marijuana as a Schedule I drug. Their definition is as follows:

"Substances in this schedule have a high potential for abuse, have no currently accepted medical use in treatment in the United States, and there is a lack of accepted safety for use of the drug or other substance under medical supervision. Some examples of substances listed in schedule I are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), peyote, methaqualone, and 3,4-methylenedioxymethamphetamine ('ecstasy')."

The Open Neurology Journal recently conducted a study of smoked and vaporized marijuana and its medical usefulness in pain management. The purpose of the study was to show that the drug is misclassified as it does have medical use and should be classified as such. This study takes to task the federal government's failure to make drug classification decisions on a scientific basis instead of fear and bias as in the case of marijuana.

The study focused on the short term effectiveness of marijuana on neuropathic pain. It was carried out by the University of California Center for Medicinal Cannabis Research (CMCR). The study showed overwhelming evidence that the use of smoked cannabis reduced pain by 30 - 40%.  The study also looked at the nausea-reducing and appetite-stimulating properties for cancer and AIDS patients and again, it showed that it was a significant improvement when compared to the placebo (38%vs 8%). So in both cases, the study suggests a valid medical use.

In the conclusion of the study the Schedule I classification by the DEA is refuted by all evidence presented through this study. Here is the following set of statements at the conclusion of the paper.

5960 61

This evidence should at the very least compel the federal government, Department of Justice, and Drug Enforcement Agency to reclassify marijuana as a Schedule III, which would allow it to be used for medical purposes instead of treated as a drug that has no redeemable qualities. I think we can all agree that marijuana has some benefits, while a drug like crack cocaine has none-- this should be apparent to all who look at this issue objectively.

Many people feel strongly one way or the other about the War on Drugs in America, but we should strive to look at the issue of drug use in a rational and scientific way. Would this harm a person? What are the benefits of this substance, medical or otherwise to the population? Would we be better off if this substance was treated like a medicine instead of strictly an illicit substance? These and many other questions must be asked by a society if we truly want to make the best decisions. This is why studies like this and others are extremely important and should be taken seriously by policy makers in Washington as well as state capitols.

Tags: News

Adhere to the IVN etiquette

By posting a comment, you agree to adhere to our etiquette rules: No partisan attacks, no personal attacks, substantiate your sources, no self-promotion.

Get IVN’s Free Weekly Newsletter:Get IVN’s Free Newsletter

Get IVN’s Free Weekly Newsletter:Get IVN’s Free Newsletter

Nonpartisan Issues. Diverse Perspectives.

Check your inbox and click the link to confirm.

Republish this article

Republishing guidelines

Republish IVN articles for free. Independent Voter News articles may be republished online or in print under a Creative Commons BY-NC-ND 4.0 license, on these terms:

  1. Credit the author and IVN. Keep the byline ("By Author Name, Independent Voter News") and the attribution note at the end, which links to the original.
  2. Keep the meaning. You may update time and place references and apply your house style. You may trim for length, as long as the cuts don't change the meaning or misrepresent the author. Keep the headline. Mark any additions as your own (for example "Additional reporting by ...").
  3. Translations are welcome. Translate faithfully, add "Translated from English by [your outlet]", and tell us at editor@ivn.us.
  4. Keep the links, including the link to the original article.
  5. Keep the tracking image. The HTML includes a 1-pixel image that counts readers on your page. It collects no personal information.
  6. Photos and illustrations. Images credited to IVN may be used with this article only. Images credited to others (AP, Getty, Unsplash, Wikimedia and so on) stay under their owners' terms. Secure the rights or switch "Include images" off.
  7. Don't sell it. You can't sell our articles or sell ads specifically against them. Your normal site advertising is fine.
  8. No implied endorsement. Don't suggest that IVN or the author endorses you, your candidates or your causes, or that donations to you support IVN.
  9. Keep labels. Opinion or analysis pieces keep that label.
  10. Point search engines to the original. Set the canonical URL of your copy to the original IVN article (the HTML we give you includes the tag).
  11. No bulk or automated republishing, and don't submit our articles to aggregators (Apple News, Google News, MSN) as your own.
  12. Corrections and removals. Update your copy when we correct it, and remove it promptly if we ask. We'll contact you at the email you give us.
  13. Questions or print republication: editor@ivn.us.

IVN staff: fill in who you're inviting above, then create the invite.

Preparing the article

Study Casts Doubt on DEA Marijuana Classification

Choose a format
  • HTML
  • Email HTML
  • Markdown
  • Formatted (.docx)
  • Plain text
  • WordPress blocks
  • PDF
Choose a platform

Photos credited to others need their owners' permission.

To for

Republishing somewhere else? Questions? editor@ivn.us